Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma

被引:26
作者
Martinez-Rivera, Vanessa [1 ]
Cristina Negrete-Garcia, Maria [1 ]
Avila-Moreno, Federico [2 ]
Ortiz-Quintero, Blanca [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Res Unit, Calzada Tlalpan 4502,Colonia Secc 16, Mexico City 14080, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Estudios Super FES Iztacala, Canc Epigen & Lung Dis Lab 12, Unidad Invest Biomed UBIMED, Ave Barrios 1 Colonia Reyes Iztacala, Mexico City 54090, DF, Mexico
关键词
malignant pleural mesothelioma; microRNAs; diagnosis biomarkers; MICRORNA EXPRESSION PROFILES; CIRCULATING MICRORNAS; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; LUNG ADENOCARCINOMA; MESSENGER-RNAS; CANCER; IDENTIFICATION; GUIDELINES; APOPTOSIS;
D O I
10.3390/ijms19020595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates in the pleura, is diagnosed in advanced stages and has a poor prognosis. Accurate diagnosis of MPM is often difficult and complex, and the gold standard diagnosis test is based on qualitative analysis of markers in pleural tissue by immunohistochemical staining. Therefore, it is necessary to develop quantitative and non-subjective alternative diagnostic tools. MicroRNAs are non-coding RNAs that regulate essential cellular mechanisms at the post-transcriptional level. Recent evidence indicates that miRNA expression in tissue and body fluids is aberrant in various tumors, revealing miRNAs as promising diagnostic biomarkers. This review summarizes evidence regarding secreted and tissue miRNAs as biomarkers of MPM and the biological characteristics associated with their potential diagnostic value. In addition to studies regarding miRNAs with potential diagnostic value for MPM, studies that aimed to identify the miRNAs involved in molecular mechanisms associated with MPM development are described with an emphasis on relevant aspects of the experimental designs that may influence the accuracy, consistency and real diagnostic value of currently reported data.
引用
收藏
页数:27
相关论文
共 100 条
[1]   Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia [J].
Abd-El-Fattah, Amal A. ;
Sadik, Nermin Abdel Hamid ;
Shaker, Olfat Gamil ;
Aboulftouh, Mariam Lotfy .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (03) :875-884
[2]   Problems in mesothelioma diagnosis [J].
Addis, Bruce ;
Roche, Heather .
HISTOPATHOLOGY, 2009, 54 (01) :55-68
[3]  
Ahmadinejad F, 2017, TUMOUR BIOL, V39, DOI DOI 10.1177/1010428317698362
[4]   MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion [J].
Ak, Guntulu ;
Tomaszek, Sandra C. ;
Kosari, Farhad ;
Metintas, Muzaffer ;
Jett, James R. ;
Metintas, Selma ;
Yildirim, Huseyin ;
Dundar, Emine ;
Dong, Jie ;
Aubry, Marie Christine ;
Wigle, Dennis A. ;
Thomas, Charles F., Jr. .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[5]  
Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]
[6]   Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma [J].
Andersen, Morten ;
Grauslund, Morten ;
Ravn, Jesper ;
Sorensen, Jens B. ;
Andersen, Claus B. ;
Santoni-Rugiu, Eric .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (04) :418-430
[7]   Malignant Mesothelioma Diagnosis [J].
Arif, Qudsia ;
Husain, Aliya N. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (08) :978-980
[8]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[9]   MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[10]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95